English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community

Regulatory

+ Regulatory
Karen Kidd | Aug 17, 2016

Ellmers says Aetna's Obamacare departure is a 'bellwether moment' for U.S. health care

+ Community
Caitlin Nordahl | Aug 17, 2016

Takeda, Ultragenyx to partner for therapy development

+ Community
Amanda Rupp | Aug 17, 2016

Study finds many U.S. children with poor cardiovascular health

+ Technology/Innovation
Amanda Rupp | Aug 16, 2016

Engles family to fund new TSC research

+ Regulatory
Amanda Rupp | Aug 16, 2016

Knowledge, patience, flexibility needed to handle autism communication

+ Regulatory
Amanda Rupp | Aug 16, 2016

FDA improves premarket safety guidelines for dietary supplements

+ Technology/Innovation
Amanda Rupp | Aug 16, 2016

Eisai, Mamorio partner on tool to support dementia patients

+ Community
Amanda Rupp | Aug 16, 2016

The Delta Companies highlights need for critical care physicians

Trending

+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate

+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update

+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'

Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation

  • « First
  • «
  • …
  • 438
  • 439
  • 440
  • 441
  • 442
  • 443
  • 444
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2026 Patient Daily